跳至主要内容
临床试验/NCT05475886
NCT05475886招募中不适用

6% Hydroxyethyl Starch (130/0.4) Coload for Postspinal Anesthesia Hypotension in Patients Undergoing Caesarean Section: A Randomized Sequential Allocation Dose-finding Study

General Hospital of Ningxia Medical University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40
试验地点
1
主要终点
ED 50 and ED 90

研究概览

简要总结

The purpose of this study is to investigate the ED50 and ED90 for an effective 6% Hydroxyethyl starch (130/0.4) coload infusion dose for postspinal anesthesia hypotension in patients undergoing cesarean section.

详细描述

Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of post-spinal anesthesia hypotension is as high as 62.1-89.7% if prophylactic measures are not taken. Colloid fluid coload has been highly demonstrated for prevention and/or treatment of post-spinal anesthesia hypotension. However, the ED50 and ED90 for an effective 6% Hydroxyethyl starch (130/0.4) coload infusion dose for postspinal anesthesia hypotension are still unknown. The purpose of this study is to investigate the ED50 and ED90 for an effective 6% Hydroxyethyl starch (130/0.4) coload infusion dose for postspinal anesthesia hypotension in patients undergoing cesarean section.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 18-40 years
  • Primipara or multipara
  • Singleton pregnancy ≥ 37 weeks
  • American Society of Anesthesiologists physical status classification I to II
  • Scheduled for elective cesarean section under spinal anesthesia

排除标准

  • Body height < 150 cm
  • Body weight > 100 kg or body mass index (BMI) ≥ 40 kg/m2
  • Eclampsia or chronic hypertension or baseline blood pressure ≥ 160mmHg
  • Hemoglobin < 7g/dl
  • Coagulation or renal function disorders
  • Known allergy to hydroxyethyl starch
  • Fetal distress, or known fetal developmental anomaly

研究组 & 干预措施

Hydroxyethyl starch (130/0.4) coload group

Experimental

An initial infusion dose of 500 ml 6% Hydroxyethyl starch (130/0.4) coload simultaneous with spinal anesthesia.

干预措施: Hydroxyethyl starch 130/0.4 (Drug)

结局指标

主要结局

ED 50 and ED 90

时间窗: 1-15 minutes after spinal anesthesia

The dose of 6% Hydroxyethyl starch (130/0.4) that would be effective in preventing postspinal anesthesia hypotension in 50% (effective dose, ED 50) and 90% (ED90) of patients

次要结局

  • The incidence of hypertension.(1-15 minutes after spinal anesthesia)
  • The incidence of post-spinal anesthesia hypotension(1-15 minutes after spinal anesthesia)
  • The incidence of bradycardia.(1-15 minutes after spinal anesthesia)
  • pH(Immediately after delivery)
  • The incidence of severe post-spinal anesthesia hypotension.(1-15 minutes after spinal anesthesia)
  • The incidence of nausea and vomiting.(1-15 minutes after spinal anesthesia)
  • Partial pressure of oxygen (PO2)(Immediately after delivery)
  • Base excess (BE)(Immediately after delivery)
  • APGAR score(5 min after delivery)

研究者

发起方
General Hospital of Ningxia Medical University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验